Proof of principle study of sequential combination atezolizumab and Vigil in relapsed ovarian cancer
Rodney P. Rocconi, Erin Stevens, Justin Bottsford-Miller, Sharad Ghamande, Jeffrey Elder, Leslie DeMars, Adnan Munkarah, Phylicia Aaron, Laura Stanbery, Gladice Wallraven, Ernest Bognar, Meghan Manley, Staci Horvath, Luisa Manning, Adam Walter, Evanthia Galanis, Thomas J. Herzog, Bradley J. Monk, Robert L. Coleman, John Nemunaitis
Topics & Concepts
VigilAtezolizumabMedicineInternal medicineAdverse effectOncologyCancerGastroenterologyImmunotherapyPembrolizumabHistoryArchaeologyCancer Immunotherapy and BiomarkersImmunotherapy and Immune ResponsesOvarian cancer diagnosis and treatment